Published Date: 13 Mar 2023
This document outlines goals for improving the quality of care in nursing homes and provides recommendations to support these efforts.
Read Full NewsThe FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.
1.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
2.
Novel ADC Improves Survival in Metastatic TNBC
3.
New Data Put ADCs on the Map in Relapsed SCLC
4.
Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
5.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
1.
Preventing Cancer-Associated Cachexia Through Early Muscle Proteolysis Signature Monitoring
2.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
3.
Pathophysiology of Bone-Marrow Fibrotic Remodeling
4.
Hematopoietic Aging Signatures and Future Hematologic Disease Risk
5.
Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Blood Clotting Disorders Explained
2.
When Unexplained Bruising May Require Blood Testing
3.
Understanding Blood Clotting Disorders
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation